Stay updated on Benralizumab in HES: Efficacy and Safety Clinical Trial
Sign up to get notified when there's something new on the Benralizumab in HES: Efficacy and Safety Clinical Trial page.

Latest updates to the Benralizumab in HES: Efficacy and Safety Clinical Trial page
- CheckyesterdayChange DetectedMinor metadata update: Revision v3.3.4 added and Revision v3.3.3 removed; no impact on page content or study details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check8 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check30 days agoChange DetectedAdded a Locations section listing state sites (California, Georgia, Maryland, Michigan, North Carolina, Ohio, Utah) and updated the page revision to v3.3.3. Removed outdated location entries and the HHS Vulnerability Disclosure from the footer.SummaryDifference0.6%

- Check44 days agoChange DetectedThe page now displays a new label 'Last Update Posted (Estimated)' and removes the old 'Last Update Posted' label. This is a minor presentation change and does not modify the study data or main content.SummaryDifference0.0%

- Check52 days agoChange DetectedThe page shows an updated revision tag to v3.3.2 (with a date) and the previous v3.3.1 tag is removed, with no visible changes to the study details.SummaryDifference0.2%

- Check59 days agoChange DetectedThe revision label changed from v3.2.0 to v3.3.1 in the page footer; no other visible content or functional changes were detected. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check66 days agoChange DetectedRemoved the government funding delay notice from the page. Core trial details, eligibility criteria, and locations remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

Stay in the know with updates to Benralizumab in HES: Efficacy and Safety Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Benralizumab in HES: Efficacy and Safety Clinical Trial page.